| |
Custom Synthesis
BASF produces customized active ingredients and advanced intermediates exclusively and in complete confidence on behalf of pharmaceutical companies. BASF’s experts offer support through the drug lifecycle - from kilo laboratory to commercial production, from the early clinical phase to market launch and even when the drug becomes generic.
In 2005 BASF acquired the Swiss fine chemicals company Orgamol, which can boast over fifty years of experience and success in the field of exclusive synthesis. Thanks to this increase in know-how and further production facilities, BASF has come to offer even more comprehensive custom synthesis services. We are now one of the leading companies in this sector.
|
We bring the right assets, the right chemistry and the right experience together.
BASF now has a U.S.-based Custom Synthesis team to serve the needs of pharmaceutical companies in North America.
Contact us today to learn how we can help you accelerate new pharmaceuticals
to market:
By phone: 001-973-245-7180
By e-mail: customsynthesis@basf.com |
|
|
 |
News |
| |
|
June 18, 2010:
BASF one of the top three best raw materials suppliers of the Sindusfarma’s Quality 2010 Prize
(english) June 18, 2010:
Investigating the Up Scaling Properties of a Sustained Release Coating Using Side Vented Pan Coating Technology
(english) April 8, 2010:
BASF showcases expertise across pharmaceutical value chain at CPhI Japan 2010
(english) March 2, 2010:
BASF showcases its expertise at the 7th World Meeting on Pharmaceutics, Biopharmaceutic and Pharmaceutical Technology in Malta
(english) February 10, 2010:
BASF has joined forces with GEA Niro in cGMP spray drying for
custom synthesis pharma production
(english, deutsch)
|
|
 |
Product Search |
 |
|
|
